Wise R, Wills P J, Bedford K A
Antimicrob Agents Chemother. 1981 Jul;20(1):30-2. doi: 10.1128/AAC.20.1.30.
Moxalactam exists in two epimeric forms, R and S. The in vitro activity of these two epimers was compared with that of material available for clinical and laboratory use (R + S moxalactam). Generally, R moxalactam was twice as active as the S form. The stability of R + S moxalactam was studied at 37, 20, 4 and -20 degrees C in buffer and serum. Only in serum at 37 degrees C was there any appreciable loss of activity (half-life, 8 h). The stability of R and S epimers was studied separately, and the composition of the resulting equilibrium was investigated. At 37 degrees C in serum, one-half of the excess of either R or S over the equilibrium mixture was converted into the equilibrium mixture in 1.5 h. The proportions of R to S in an equilibrium mixture in buffer were 50:50, but in serum they were 45:55. It is doubtful whether these differences in stability and activity will have any significant clinical importance.
拉氧头孢存在两种差向异构体形式,R型和S型。将这两种差向异构体的体外活性与临床和实验室可用物质(R+S拉氧头孢)的活性进行了比较。一般来说,R型拉氧头孢的活性是S型的两倍。在37、20、4和-20℃下,于缓冲液和血清中研究了R+S拉氧头孢的稳定性。仅在37℃的血清中出现了明显的活性损失(半衰期为8小时)。分别研究了R型和S型差向异构体的稳定性,并对所得平衡的组成进行了研究。在37℃的血清中,R或S相对于平衡混合物的过量部分的一半在1.5小时内转化为平衡混合物。缓冲液中平衡混合物中R与S的比例为50:50,但在血清中为45:55。这些稳定性和活性的差异是否具有任何显著的临床意义尚不确定。